News

It wasn’t the thundering arm of Caleb Eschenberg or a deft pass from Ryker Daniels that set the tone early in the CIF-Southern Section Division 5 quarterfinals between Newbury Park and Oak Park ...
There’s no doubt that Newbury Park High is synonymous with distance running. But the school's current class of boys sprinters have been expanding the brand this spring. Newbury Park senior ...
CHATSWORTH — Sierra Canyon and Newbury Park have never played each other in an actual football game, but their presence brought out over 40 colleges to the Trailblazers’ College Showcase on a ...
Tempus enters earnings with strong tailwinds but elevated scrutiny. The stock has surged over 80% in the past six months, and analysts have maintained tight but bullish targets — averaging $61. ...
Former Newbury Park High quarterback Cam Rising has returned to his alma mater as the offensive coordinator of the varsity football team. The hire was officially announced on social media ...
Tempus AI posted Q1 revenue of $255.74M and a smaller-than-expected loss, signaling strong momentum in precision medicine. Analyst highlights $1B+ in total contract value and 25% topline growth ...
Tempus AI Inc. TEM during the first quarter secured a multi-million dollar deal to build “the world’s largest foundation model for oncology.” “And this is big for a few reasons,” said ...
Please go ahead. Thank you. Good afternoon and welcome to Tempus' first quarter 2025 conference call. This afternoon, Tempus released results for the quarter ended March 31, 2025. The press ...
CHICAGO, May 05, 2025--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, has announced the launch of ...
Please go ahead. Thank you. Good afternoon. And welcome to Tempus’ first quarter 2025 conference call. This afternoon, Tempus released results for the quarter ended March 31, 2025. The press ...
Acquisition related expenses consist of legal, diligence, accounting, and financing costs incurred for the acquisitions of Ambry and Deep 6 during the three months ended March 31, 2025. The ...
Tempus AI is a leader in applying AI solutions to cancer diagnosis. The company announced a new platform for speeding up the discovery of new drug targets. Since it's still unprofitable, Tempus AI ...